ChiroBlock will be represented by Alexander Gutsche at Nordic Life Science Days 2026 in Stockholm. The event takes place on 8–9 September 2026 and brings together biotech and medtech companies, pharmaceutical decision-makers, investors, researchers and international life science organisations.

Event at a glance

• Event: Nordic Life Science Days 2026
• Date: 8–9 September 2026
• Venue: Kistamässan, Arne Beurlings torg 5, Kista, Stockholm, Sweden
• ChiroBlock representative: Alexander Gutsche
• Focus: Life science partnering, biotechnology, pharmaceutical innovation, investment and international collaboration

Why is ChiroBlock attending Nordic Life Science Days?

Nordic Life Science Days is a leading partnering event for the Nordic life science ecosystem. Its participants include biotech and medtech companies, pharmaceutical organisations, investors, researchers, start-ups and international delegations.

The event is particularly relevant to ChiroBlock because many life science projects eventually face a chemical challenge: a required molecule is not commercially available, an existing synthesis route is not reproducible or scalable, or a compound is needed with a project-specific purity and impurity profile.

This is where specialised chemical custom synthesis becomes an enabling part of pharmaceutical and biotechnology research.

Stockholm and Uppsala together host more than half of Sweden’s life science companies and employees, according to the official NLSDays venue information. Meeting this ecosystem in Stockholm creates opportunities to understand emerging molecular requirements at an early stage and to discuss how external synthetic chemistry can support their development.

Where does custom synthesis support life science innovation?

Life science programmes may require compounds that cannot simply be ordered from a catalogue. Typical examples include:

• novel research compounds and proof-of-concept molecules,
• pharmaceutical intermediates and building blocks,
• metabolites and degradation products,
• API impurities and analytical reference compounds,
• stable-isotope-labelled compounds,
• alternative or optimised synthesis routes,
• reproducible supply from milligram to kilogram scale.

For start-ups, access to external chemistry can help bridge the gap between an initial molecular concept and the first reproducible supply of material. Established pharmaceutical and biotechnology companies may require additional expertise for route scouting, difficult multi-step syntheses, process optimisation or compounds with application-specific specifications.

ChiroBlock’s role is focused on synthetic chemistry: developing and performing synthesis routes for complex, novel and non-commercially available molecules while protecting confidential project information and intellectual property.

Examples of ChiroBlock’s contribution to independently published research projects can be found in our scientific custom synthesis references.

One-to-one partnering in Stockholm

Nordic Life Science Days uses the partneringONE platform to support targeted one-to-one meetings between participants. This makes the event particularly suitable for discussing clearly defined development needs, potential collaborations and specific molecular challenges.

Meet Alexander Gutsche at NLSDays 2026

Are you attending Nordic Life Science Days in Stockholm?

If your pharmaceutical, biotechnology or life science project requires a complex compound, a non-commercially available molecule, an analytical reference substance or a more scalable synthesis route, arrange a conversation with Alexander Gutsche on LinkedIn.

We look forward to scientific discussions, new perspectives and relevant connections in Stockholm.